Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab

Figure 1

Scatterplots of calprotectin levels with corresponding sum B-mode (BM) or power Doppler (PD) scores. The scatterplots illustrate the distribution of the calprotectin levels with the corresponding total sum B-mode (BM) or power Doppler (PD) scores at baseline and at three months examination.

Back to article page